Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Chianchinon Apr 29, 2023 8:54am
174 Views
Post# 35420643

The winners are out proud to have lost fortunes

The winners are out proud to have lost fortunesGUD, traded at $10.50 nine Years ago and had nearly one billion in cash. Now most of the cash is invested and gone to LATAM and no profits to be seen in the horizon. Sales means nothing when they are generated below cost. The market is punishing MNGT who can no longer continue the buy back above $5 as cash is running low. MNGT made a horrible decision to buy back shares at an overpriced cost of over $5. The did the same in LATAM overpaid and no profits.  Now at last short sellers are feasting on GUD while mugsy and cronies’ aliases are deep in the red and no one to save them.  
GUD AT BEST IS WORTH LESS THAN $2  just a matter of time when MNGT and BOD will move on in pride of their accomplishments 
<< Previous
Bullboard Posts
Next >>